Portefeuille d'ETF IYH (NYSE) - Page 4 | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

JAZZ JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY 6.1 M 29.8 K 0.2%

ALGN ALIGN TECHNOLOGY, INC. 6.1 M 34.4 K 0.2%

EXEL EXELIXIS, INC. 6.0 M 135.0 K 0.2%

ELAN ELANCO ANIMAL HEALTH INCORPORATED 5.7 M 253.1 K 0.2%

BMRN BIOMARIN PHARMACEUTICAL INC. 5.2 M 97.4 K 0.2%

GMED GLOBUS MEDICAL, INC. 5.2 M 57.5 K 0.2%

EHC ENCOMPASS HEALTH CORPORATION 5.1 M 51.2 K 0.2%

SOLV SOLVENTUM CORPORATION 5.1 M 75.7 K 0.2%

MOH MOLINA HEALTHCARE, INC. 5.1 M 26.0 K 0.2%

RVTY REVVITY, INC. 5.0 M 58.1 K 0.2%

MEDP MEDPACE HOLDINGS, INC. 4.8 M 11.5 K 0.2%

BAX BAXTER INTERNATIONAL INC. 4.6 M 263.9 K 0.2%

UHS UNIVERSAL HEALTH SERVICES, INC. 4.5 M 26.9 K 0.2%

TECH BIO-TECHNE CORPORATION 4.4 M 79.5 K 0.2%

CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 4.2 M 25.0 K 0.1%

M

MASI MASIMO CORPORATION 4.1 M 23.2 K 0.1%

HSIC HENRY SCHEIN, INC. 3.9 M 52.2 K 0.1%

HALO HALOZYME THERAPEUTICS, INC. 3.8 M 59.7 K 0.1%

QGEN Qiagen N.V. 3.6 M 103.7 K 0.1%

RGEN REPLIGEN CORPORATION 3.2 M 27.0 K 0.1%

1
2
3
4
5
6

Nouvelles

L'approbation de la FDA pour le traitement combiné d'AbbVie/AstraZeneca pourrait établir une nouvelle norme pour le cancer du sang à croissance lente | Benzinga France

Boisson Monster, UnitedHealth, Thermo Fisher Scientific et plus: "Final Trades" de CNBC | Benzinga France